NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/gsk-lawsuit-submission-form?prid=128818&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Revance Therapeutics, Inc. (NASDAQ:RVNC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/revance-therapeutics-inc-lawsuit-submission-form?prid=128819&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of e.l.f. Beauty, Inc. ("e.l.f.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/icon-public-limited-company-lawsuit-submission-form?prid=128833&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Micron Technology, Inc. (NASDAQ:MU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/micron-technology-inc-lawsuit-submission-form?prid=128831&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/joint-stock-company-kaspi-kz-lawsuit-submission-form?prid=128832&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Caribou Biosciences, Inc. (NASDAQ:CRBU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/caribou-biosciences-inc-lawsuit-submission-form?prid=128823&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/novo-nordisk-a-s-lawsuit-submission-form?prid=128830&wire=1 or contact Joseph E. Levi, Esq.

SAN DIEGO, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Edison International (NYSE: EIX) publicly traded securities between February 25, 2021 and February 6, 2025, inclusive (the “Class Period”), have until April 14, 2025 to seek appointment as lead plaintiff of the Edison International class action lawsuit. Captioned Antillon v. Edison International, No. 25-cv-01154 (C.D. Cal.), the Edison International class action lawsuit charges Edison International and certain of Edison International's top executives with violations of the Securities Exchange Act of 1934.

Riley's credit facility maturity was extended by more than two years, and it received a $25 million borrowing base increase. Riley expects to spend $130 million over the next two years on midstream infrastructure. These investments should help Riley's realized price for natural gas and NGLs, which were both slightly negative during the first three quarters of 2024.

Shares of Axcelis Technologies (ACLS -12.25%) sank in Tuesday's trading. The stock ended today's session down 12.3% and had been down as much as 14.6% earlier in the day.

CEO Charles Liang said he is "confident" that the company will file its delayed annual report by the U.S. Securities and Exchange Commission's Feb. 25 deadline. The company also said it expects to hit $40 billion in revenue in fiscal 2026.

MUSCATINE, Iowa--(BUSINESS WIRE)--HNI Corporation Announces Quarterly Dividend.

A short-seller ripped into Pagaya Technologies (PGY -13.03%) in a report published on Tuesday, and the market reacted accordingly. The document raised enough concern to generate an investor sell-off, with the stock closing 13% lower as a result.

Astera Labs reported its sixth consecutive quarter of record revenues and posted its first quarter of GAAP profitability as a public company in Q4 2024. Astera Labs' robust growth and better cost management are leading to impressive free cash flow generation. I expect Astera Labs' topline and bottom line performance to further improve in 2025 due to hyperscalers' AI CapEx outlook and the production ramp up of Leo and Scorpio products.

The 'Fast Money' traders talk Tesla's struggling stock as Elon Musk's focus shifts to Washington.

Global real estate investment trust (REIT) specialist W.P. Carey (WPC 0.74%) reported mixed fourth-quarter earnings on Tuesday, Feb. 11.

Coca-Cola (KO 4.72%) stock posted substantial gains in Tuesday's trading. The beverage giant's share price ended the session up 4.7% in a day of trading that saw the S&P 500's (^GSPC 0.03%) level wind up approximately in line with yesterday's close.

NEUMORA THERAPEUTICS, INC. (NASDAQ: NMRA) INVESTOR ALERT: Investors With Large Losses in Neumora Therapeutics, Inc. Should Contact Bernstein Liebhard LLP

Biohaven's NDA for Troriluzole in spinocerebellar ataxia was accepted by the FDA with Priority Review, potentially leading to approval in Q3 2025. BHV-7000, a selective Kv7 activator, is being studied for bipolar disorder and MDD, with data expected in 2025. The global major depressive disorder treatment market is expected to reach $14.96 billion by 2032.